Systems Medicine in Pharmaceutical Research and Development
The development of new drug therapies requires substantial and ever increasing investments from the pharmaceutical company. Ten years ago, the average time from early target identification and optimization until initial market authorization of a new drug compound took more than 10 years and involved costs in the order of one billion US dollars. Recent studies indicate even a significant growth of costs in the meanwhile, mainly driven by the increasing complexity of diseases addressed by pharmaceutical research.
Source: Springer protocols feed by Bioinformatics - Category: Bioinformatics Source Type: news
More News: Bioinformatics | Study